Nanomedicine for Prostate Cancer Treatment

Ahmad Mobed,Zinat Sargazi,Reza Kheradmand,Bita Abdi,Reza Soleimany,Amin Mehra,Morad Kohandel Gargari,Homa Kohandel Gragari

DOI: https://doi.org/10.1007/s12668-024-01459-0

2024-05-29

BioNanoScience

Abstract:Prostate cancer (PrC) is the most common cancer — after skin cancer — and the fifth most aggressive neoplasm among men worldwide. In most cases, PrC grow slowly and are limited to the prostate, where they may not cause serious damage. However, although some types of prostate cancer grow slowly and may require little or no treatment, other types are highly malignant and can spread quickly. The two main treatments for early-stage prostate cancer are surgery and radiation therapy, in general. The treatment of men with prostate cancer includes surgical surgery, radiotherapy, hormone therapy, brachytherapy, chemotherapy, and using nano drugs. Nanotechnology in cancer medicine has increased the effectiveness of drugs with the targeted development of anti-cancer drugs by nanosystems. This article presents an overview of recent advances in PrC nanomedicine, especially nano drugs in the treatment of prostate cancer.